As of May 2022 Summit Therapeutics has a market cap of $0.10 Billion. This makes Summit Therapeutics the world's 5742th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to mesure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2022 | $0.11 B | -57.82% |
2021 | $0.26 B | -32.01% |
2020 | $0.38 B | 259.7% |
2019 | $0.10 B | 468.07% |
2018 | $0.01 B | -88.56% |
2017 | $0.16 B | 57.11% |
2016 | $0.10 B | -25.33% |
2015 | $0.14 B |
On May 15th, 2022 the market cap of Summit Therapeutics was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
![]() Sarepta Therapeutics
SRPT | $5.94 B | 5,673.47% | ๐บ๐ธ USA |
![]() Merrimack Pharmaceuticals MACK | $0.06 B | -32.32% | ๐บ๐ธ USA |
![]() Coherus BioSciences
CHRS | $0.59 B | 474.12% | ๐บ๐ธ USA |
![]() Arena Pharmaceuticals
ARNA | $6.16 B | 5,884.09% | ๐บ๐ธ USA |